​

BioNexus Gene Lab (BGLC) Revenue & Revenue Breakdown

OverviewFinancialsChart

BioNexus Gene Lab Revenue Highlights

Latest Revenue (Y)

$9.77M

Latest Revenue (Q)

$2.63M

BioNexus Gene Lab Revenue by Period

BioNexus Gene Lab Revenue by Year

DateRevenueChange
2023-12-31$9.77M-10.60%
2022-12-31$10.93M-18.21%
2021-12-31$13.36M17.31%
2020-12-31$11.39M8872.03%
2019-12-31$126.95K-40.21%
2018-12-31$212.33K-

BioNexus Gene Lab generated $9.77M in revenue during NA 2023, up -10.60% compared to the previous quarter, and up 4601.75% compared to the same period a year ago.

BioNexus Gene Lab Revenue by Quarter

DateRevenueChange
2024-09-30$2.63M33.21%
2024-06-30$1.97M-17.10%
2024-03-31$2.38M4.79%
2023-12-31$2.27M-10.99%
2023-09-30$2.55M-0.51%
2023-06-30$2.57M7.98%
2023-03-31$2.38M-16.28%
2022-12-31$2.84M10.27%
2022-09-30$2.58M3.62%
2022-06-30$2.49M-17.95%
2022-03-31$3.03M-6.67%
2021-12-31$3.25M-9.25%
2021-09-30$3.58M15.65%
2021-06-30$3.09M-10.35%
2021-03-31$3.45M-69.64%
2020-12-31$11.36M48301.98%
2020-09-30$23.47K258.83%
2020-06-30$6.54K-99.79%
2020-03-31$3.07M5687.15%
2019-12-31$53.05K119.46%
2019-09-30$24.17K11.68%
2019-06-30$21.64K-22.94%
2019-03-31$28.09K198.59%
2018-12-31$9.41K-89.73%
2018-09-30$91.63K-17.67%
2018-06-30$111.30K100.00%
2018-03-31--100.00%
2017-12-31$64.52K-

BioNexus Gene Lab generated $2.63M in revenue during Q3 2024, up 33.21% compared to the previous quarter, and up 102.47% compared to the same period a year ago.

BioNexus Gene Lab Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FULH.B. Fuller$3.51B$917.93M
NEUNewMarket$2.70B$724.95M
IOSPInnospec$1.95B$435.00M
OECOrion Engineered Carbons$1.89B$463.40M
ALTOAlto Ingredients$1.22B$251.81M
BCPCBalchem$922.44M$239.94M
PRMPerimeter Solutions, SA$322.11M$127.28M
GEVOGevo$17.20M$1.97M
BGLCBioNexus Gene Lab$9.77M$2.63M
SNESSenesTech$1.85M$482.00K
LOOPLoop Industries$153.00K$-6.00K
CRKNCrown ElectroKinetics--

BGLC Revenue FAQ

What is BioNexus Gene Lab’s yearly revenue?

BioNexus Gene Lab's yearly revenue for 2023 was $9.77M, representing a decrease of -10.60% compared to 2022. The company's yearly revenue for 2022 was $10.93M, representing a decrease of -18.21% compared to 2021. BGLC's yearly revenue for 2021 was $13.36M, representing an increase of 17.31% compared to 2020.

What is BioNexus Gene Lab’s quarterly revenue?

BioNexus Gene Lab's quarterly revenue for Q3 2024 was $2.63M, a 33.21% increase from the previous quarter (Q2 2024), and a 3.00% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.97M, a -17.10% decrease from the previous quarter (Q1 2024), and a -23.07% decrease year-over-year (Q2 2023). BGLC's quarterly revenue for Q1 2024 was $2.38M, a 4.79% increase from the previous quarter (Q4 2023), and a 0.20% increase year-over-year (Q1 2023).

What is BioNexus Gene Lab’s revenue growth rate?

BioNexus Gene Lab's revenue growth rate for the last 3 years (2021-2023) was -26.88%, and for the last 5 years (2019-2023) was 7596.28%.